COMMUNIQUÉS West-GlobeNewswire

Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress
20/05/2026
Conference call and webcast to discuss results to be held on June 22, 2026 at 8 a.m. ET IRVINE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the [...]
Johns Hopkins Health Plans Awards $60,000 to Maryland and Virginia Organizations
20/05/2026
Corporate Giving Program Supports Nonprofits Addressing Food Insecurity, Healthy Aging and Child Advocacy HANOVER, Md., May 20, 2026 (GLOBE NEWSWIRE) -- Johns Hopkins Health Plans has announced new recipients of its [...]
CVRx to Present at the William Blair 46th Annual Growth Stock Conference
20/05/2026
MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
20/05/2026
SUNNYVALE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
Nyxoah Accueille la Fédération Flamande des Investisseurs (VFB) à LégiaPark à la Suite des Résultats du Premier Trimestre 2026 et de la Dynamique Commerciale aux États-Unis
20/05/2026
Nyxoah Accueille la Fédération Flamande des Investisseurs (VFB) à LégiaPark à la Suite des Résultats du Premier Trimestre 2026 et de la Dynamique Commerciale aux États-Unis Mont-Saint-Guibert, Belgique – 20 mai 2026, [...]
Nanobiotix Announces Launch of Global Follow-On Offering
21/05/2026
PARIS and CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based [...]
Cytokinetics to Hold Annual Meeting of Stockholders
20/05/2026
SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 27, 2026 at 10:00 AM Pacific [...]
Nanobiotix Announces Launch of Global Follow-On Offering
21/05/2026
PARIS and CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/05/2026
WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum
20/05/2026
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum Mont-Saint-Guibert, Belgium – May 20, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext [...]
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026
SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one [...]
Information on the total number of voting rights and shares
20/05/2026
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), May 20, 2026 , 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the [...]
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
20/05/2026
State-Funded Firefighter Cancer Screening Programs Expected to Drive Meaningful Revenue Growth Beginning in Q2 2026 $5.0 Million Private Placement Strengthens Cash Position to $4.2 Million as of March 31, 2026 Recent [...]
Nanobiotix annonce le lancement d’une offre globale
21/05/2026
Paris, France ; Cambridge, Massachusetts (USA), 20 mai 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – « Nanobiotix » ou la « Société »), une société de biotechnologie au stade clinique et en phase [...]
FDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday Products
20/05/2026
Agency takes action to combat unauthorized tobacco products resembling candy, breath strips, and cough drops Silver Spring, MD, May 20, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration announced today that [...]
AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement
20/05/2026
OCALA, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc . (NYSE American: AIM) (“AIM” or the “Company”, today announced that it has entered into definitive agreements for a registered direct offering priced at- [...]
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
20/05/2026
Jupiter, FL, May 20, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on central nervous system disorders and [...]
How To Boost Testosterone After 40?| Safe Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Energy, Stamina and Performance in 2026 – Launched By Testoprime
20/05/2026
Testo Prime Launched Safe and Natural Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Read User Guide to Best Result For Energy, Stamina and Performance New York City, May 20, 2026 (GLOBE NEWSWIRE) -- IN [...]
MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications
20/05/2026
agenT-797 demonstrates pathogen suppression, lung immune restoration and tissue repair activation, supporting Ongoing Phase 2 trial Sequential immunotherapy with agenT-797 and N-803, an FDA-approved IL-15 superagonist, [...]

Pages